Biomarkers of Cardiometabolic Risk, Inflammation and Disease
Springer International Publishing (Verlag)
978-3-319-16017-7 (ISBN)
Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders.
Filipe Palavra, MDLaboratory of Pharmacology and Experimental TherapeuticsInstitute for Biomedical Imaging and Life Sciences (IBILI)Faculty of Medicine, Coimbra UniversityCoimbra, Portugal Flávio Reis, PhDLaboratory of Pharmacology and Experimental TherapeuticsInstitute for Biomedical Imaging and Life Sciences (IBILI)Faculty of Medicine, Coimbra UniversityCoimbra, Portugal Daniela Marado, MDDepartment of Internal Medicine – BCentro Hospitalar e Universitário de CoimbraCoimbra, Portugal Armando Sena, MD, PhDInterdisciplinary Centre of Research Egas Moniz, CiiEMCaparica, Portugal
Inflammation biomarkers and cardiometabolic risk.- Cardiovascular disease.- Diabetes mellitus and metabolic syndrome.- Ischemic stroke.- Chronic kidney disease.- Immune-mediated inflammatory rheumatic diseases.- Cardiometabolic risk, inflammation and neurodegenerative disorders.
| Erscheint lt. Verlag | 22.4.2015 |
|---|---|
| Zusatzinfo | X, 165 p. 11 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Gewicht | 432 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Neurologie |
| Schlagworte | Biomarkers • cardiometabolic risk • Cardiovascular Disease • Diabetes • Metabolic Syndrome • stroke |
| ISBN-10 | 3-319-16017-6 / 3319160176 |
| ISBN-13 | 978-3-319-16017-7 / 9783319160177 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
